Mitchell Kronenberg received a Ph.D. from the California Institute of Technology and was on the faculty of the UCLA School of Medicine (1986-1997). He joined the La Jolla Institute for Immunology (LJI) and served as LJI President (2003-2021). He is currently the LJI Chief Scientific Officer. Dr. Kronenberg’s research interests include innate-like T cells, the regulation of mucosal immunology and the pathogenesis of inflammatory bowel disease. He has co-authored approximately 400 publications, is an ISI highly cited investigator, and is a fellow of the American Association for the Advancement of Science (AAAS), a Distinguished Fellow of the American Association of Immunologists, and recipient of an NIH MERIT award. He is an advisor to many non-profit organizations including the Board of Scientific Counselors of the US National Cancer Institute, as well as biotech companies.
Mitchell Kronenberg PhD
Chief Scientific Officer, President Emeritus, La Jolla Institute for ImmunologyAdjunct Professor, Molecular Biology, UC San Diego School Of Biological Sciences
